Tag Archives: SCYX

SCYNEXIS (SCYX) Receives a Buy from H.C. Wainwright

In a report released today, Oren Livnat from H.C. Wainwright reiterated a Buy rating on SCYNEXIS (SCYX – Research Report), with a price target of $3.50. The company’s shares closed last Tuesday at $0.88. According to TipRanks.com, Livnat is a

Analysts’ Top Healthcare Picks: SCYNEXIS (SCYX), Selecta Biosciences (SELB)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SCYNEXIS (SCYX – Research Report) and Selecta Biosciences (SELB – Research Report) with bullish sentiments. SCYNEXIS (SCYX) Maxim Group analyst Jason McCarthy

Analysts Offer Insights on Healthcare Companies: SCYNEXIS (NASDAQ: SCYX) and Outlook Therapeutics (NASDAQ: OTLK)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on SCYNEXIS (SCYX – Research Report) and Outlook Therapeutics (OTLK – Research Report) with bullish sentiments. SCYNEXIS (SCYX) Ladenburg Thalmann & Co. analyst

Ladenburg Thalmann & Co. Maintains Their Buy Rating on SCYNEXIS (SCYX)

In a report released today, Michael Higgins from Ladenburg Thalmann & Co. maintained a Buy rating on SCYNEXIS (SCYX – Research Report), with a price target of $6.00. The company’s shares closed last Monday at $1.05. According to TipRanks.com, Higgins

SCYNEXIS (SCYX) Receives a Buy from Needham

Needham analyst Alan Carr maintained a Buy rating on SCYNEXIS (SCYX – Research Report) today and set a price target of $5.00. The company’s shares closed last Monday at $1.16. According to TipRanks.com, Carr is a 1-star analyst with an

SCYNEXIS (SCYX) Gets a Buy Rating from Ladenburg Thalmann & Co.

Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on SCYNEXIS (SCYX – Research Report) today and set a price target of $6.00. The company’s shares closed last Monday at $1.35. According to TipRanks.com, Higgins is ranked 0